The amyloidogenic cleavage of the amyloid precursor protein (APP) results in the aggregation and accumulation of β-amyloid (Aβ) in senile plaques, which lead to inflammation, tauopathies, and consequent synaptic loss characteristic of Alzheimer’s disease (AD) [1]. This evidence concerns the gene APP and Alzheimer disease.